Life Science Compliance Update

July

2017

Pharmaceutical and Device Manufacturers: Buyer Seller Beware

Written by , Posted in False Claims

John Kelly, Matt Curley and Rob Platt

Pharmaceutical and medical device manufacturers continue to face intense scrutiny from regulatory and enforcement agencies, as well as whistleblowers seeking large payouts for disclosing potential wrongdoing. There are a number of risk areas (some new, some not-so-new) that provide the basis for the government and relators to pursue alleged violations of the False Claims Act liability. Some of those areas are discussed below.

Menu Title